Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.20
-0.17 (-2.67%)
Aug 14, 2025, 11:44 AM - Market open

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
158105145110--
Market Cap Growth
92.04%-27.66%31.58%---
Enterprise Value
1358712286--
Last Close Price
6.375.418.347.50--
PB Ratio
9.0110.7611.847.72--
P/TBV Ratio
9.6110.7611.847.72--
Quick Ratio
2.642.082.743.232.37-
Current Ratio
2.672.092.753.302.41-
Return on Equity (ROE)
-150.12%-173.41%-168.51%-206.81%-609.74%-
Return on Assets (ROA)
-63.38%-65.64%-69.14%-83.30%--
Return on Capital (ROIC)
-97.67%-113.21%-103.60%-122.13%-171.30%-
Earnings Yield
-13.61%-18.18%-15.40%-17.38%--
Buyback Yield / Dilution
-15.99%-10.01%-22.90%-196.55%-9.44%-
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q